---
schema_version: "secwatch.filing_event.v1"
accession: "0001737287-24-000062"
form_type: "8-K"
ticker: "ALLO"
cik: "0001737287"
company_name: "Allogene Therapeutics, Inc."
filed_at: "2024-10-07T23:59:59+00:00"
generated_at: "2026-05-30T19:22:15.087980+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Allogene Therapeutics amends Code of Business Conduct and Ethics

## Summary
- Updates insider trading policy, antitrust restrictions, and conflicts-of-interest procedures.
- Expands fair dealing obligations, gift/entertainment restrictions, and data privacy/cybersecurity requirements.
- Adds express requirement to comply with all other Company policies supporting the Code.
- Applies to all directors, officers, employees, and certain consultants/contractors.

## SEC filing metadata
- accession: 0001737287-24-000062
- form_type: 8-K
- ticker: ALLO
- cik: 0001737287
- company_name: Allogene Therapeutics, Inc.
- filed_at: 2024-10-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.05, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737287/000173728724000062/0001737287-24-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737287/000173728724000062/allo-20241003.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001737287-24-000062
- JSON: https://secwatch.observer/filing/0001737287-24-000062.json
- Plain text: https://secwatch.observer/filing/0001737287-24-000062.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.